Table 3 Prevalence of prothrombin G20210A mutation and its association with SCD in Palestinian patients
Patient (n) | Prothrombin G20210A | Crude | Adjusted | ||||
|---|---|---|---|---|---|---|---|
G/G | G/A | A/A | OR (95% CI) | P value | OR (95% CI) | P value | |
SS (59) | 56 | 3 | 0 | 8.4(1.8–56.4) | 0.16 | 6.3(1.17–33.9) | 0.12 |
AS (25) | 24 | 1 | 0 | 5.5(1.1–66.2) | 0.13 | 3.71(0.46–26.1) | 0.18 |
S/Thal (33) | 29 | 4 | 0 | 9.4(1.9–54.4) | 0.09 | 3.39(0.33–43.4) | 0.21 |
Controls | 112 | 6 | 0 | 1 | – | 1 | – |